Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Development of oral immunomodulatory agents in the management of multiple sclerosis.

Nicholas R, Giannetti P, Alsanousi A, Friede T, Muraro PA.

Drug Des Devel Ther. 2011;5:255-74. doi: 10.2147/DDDT.S10498. Epub 2011 May 10. Review.

PMID:
21625416
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.

Gold R.

CNS Drugs. 2011 Jan;25(1):37-52. doi: 10.2165/11539820-000000000-00000. Review.

PMID:
21128693
[PubMed - indexed for MEDLINE]
3.

Emerging oral drugs for relapsing-remitting multiple sclerosis.

Gasperini C, Ruggieri S.

Expert Opin Emerg Drugs. 2011 Dec;16(4):697-712. doi: 10.1517/14728214.2011.642861. Epub 2011 Dec 7. Review.

PMID:
22148963
[PubMed - indexed for MEDLINE]
4.

Teriflunomide for multiple sclerosis.

He D, Xu Z, Dong S, Zhang H, Zhou H, Wang L, Zhang S.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009882. doi: 10.1002/14651858.CD009882.pub2. Review.

PMID:
23235682
[PubMed - indexed for MEDLINE]
5.

Immune therapy of multiple sclerosis--future strategies.

Meuth SG, Göbel K, Wiendl H.

Curr Pharm Des. 2012;18(29):4489-97. Review.

PMID:
22612746
[PubMed - indexed for MEDLINE]
6.

Established and novel disease-modifying treatments in multiple sclerosis.

Cross AH, Naismith RT.

J Intern Med. 2014 Apr;275(4):350-63. doi: 10.1111/joim.12203. Epub 2014 Mar 11. Review.

PMID:
24444048
[PubMed - indexed for MEDLINE]
7.

New oral drugs for multiple sclerosis.

Gasperini C, Ruggieri S.

Neurol Sci. 2009 Oct;30 Suppl 2:S179-83. doi: 10.1007/s10072-009-0146-3. Review.

PMID:
19882371
[PubMed - indexed for MEDLINE]
8.

Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.

Thöne J, Ellrichmann G.

Drug Healthc Patient Saf. 2013;5:37-47. doi: 10.2147/DHPS.S28822. Epub 2013 Feb 26.

PMID:
23459383
[PubMed]
Free PMC Article
9.

Treatment options for multiple sclerosis: current and emerging therapies.

Gawronski KM, Rainka MM, Patel MJ, Gengo FM.

Pharmacotherapy. 2010 Sep;30(9):916-27. doi: 10.1592/phco.30.9.916. Review.

PMID:
20795847
[PubMed - indexed for MEDLINE]
10.

Teriflunomide for oral therapy in multiple sclerosis.

Papadopoulou A, Kappos L, Sprenger T.

Expert Rev Clin Pharmacol. 2012 Nov;5(6):617-28. doi: 10.1586/ecp.12.56.

PMID:
23234322
[PubMed - indexed for MEDLINE]
11.

Oral laquinimod treatment in multiple sclerosis.

Fernández O.

Neurologia. 2011 Mar;26(2):111-7. doi: 10.1016/j.nrl.2010.07.027. Review. English, Spanish.

PMID:
21163185
[PubMed - indexed for MEDLINE]
Free Article
12.

Emerging oral therapies in multiple sclerosis.

Conway D, Cohen JA.

Curr Neurol Neurosci Rep. 2010 Sep;10(5):381-8. doi: 10.1007/s11910-010-0125-3.

PMID:
20549393
[PubMed - indexed for MEDLINE]
13.

Emerging multiple sclerosis oral therapies.

Rammohan KW, Shoemaker J.

Neurology. 2010 Jan 5;74 Suppl 1:S47-53. doi: 10.1212/WNL.0b013e3181c97f89.

PMID:
20038763
[PubMed - indexed for MEDLINE]
14.

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.

Melzer N, Meuth SG.

Clin Exp Immunol. 2014 Mar;175(3):359-72. doi: 10.1111/cei.12195. Review.

PMID:
24032475
[PubMed - indexed for MEDLINE]
15.

Current and future disease-modifying therapies in multiple sclerosis.

Lim SY, Constantinescu CS.

Int J Clin Pract. 2010 Apr;64(5):637-50. doi: 10.1111/j.1742-1241.2009.02261.x. Review.

PMID:
20456216
[PubMed - indexed for MEDLINE]
16.

Oral laquinimod therapy in relapsing multiple sclerosis.

Preiningerova J.

Expert Opin Investig Drugs. 2009 Jul;18(7):985-9. doi: 10.1517/13543780903044944. Review.

PMID:
19527103
[PubMed - indexed for MEDLINE]
17.

The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation.

Leist TP, Vermersch P.

Curr Med Res Opin. 2007 Nov;23(11):2667-76. Review.

PMID:
17880754
[PubMed - indexed for MEDLINE]
18.

Novel therapeutic approaches to autoimmune demyelinating disorders.

Sanvito L, Constantinescu CS, Gran B.

Curr Pharm Des. 2011;17(29):3191-201. Review.

PMID:
21864270
[PubMed - indexed for MEDLINE]
19.

Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets.

Gasperini C, Ruggieri S, Pozzilli C.

Ther Clin Risk Manag. 2010 Sep 7;6:391-9.

PMID:
20856685
[PubMed]
Free PMC Article
20.

Current and future role of interferon beta in the therapy of multiple sclerosis.

Farrell RA, Giovannoni G.

J Interferon Cytokine Res. 2010 Oct;30(10):715-26. doi: 10.1089/jir.2010.0089. Review.

PMID:
20874249
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk